The Lifescience Committee is designed to boost visibility and access for Swiss biotech and medtech companies in China, providing increased opportunities for success in the Chinese market.
The LSC will be working to create events, round-table discussions, and other activities in the areas of policy, commercialization, partnerships, digital transformation, and more.
